多能性的遗传和表观遗传调节者
M Azim Surani1, Katsuhiko Hayashi, Petra Hajkova
1Wellcome Trust/Cancer Research UK Gurdon Institute, University of Cambridge, Tennis Court Road, Cambridge CB2 1QN, UK. as10021@mole.bio.cam.ac.uk
Cell
|February 27, 2007
概括
表观遗传机制指导细胞的发育,从胚胎细胞到多能细胞,甚至更远. 了解这些过程可以从成体体细胞直接产生多能细胞.
科学领域:
- 发展生物学 发展生物学
- 表观遗传学 在表观遗传学中,表观遗传学是指表观遗传学.
- 干细胞生物学 干细胞生物学
背景情况:
- 细胞发育需要精确的遗传和表观遗传调节.
- 在早期胚胎中发现的多能细胞可以分化为各种细胞类型.
- 表观遗传修饰对于细胞命运的决定和重编程至关重要.
研究的目的:
- 阐明早期哺乳动物发育过程中控制细胞转变的遗传和表观遗传机制.
- 了解支持多能性的表观遗传状态在体外.
- 探索再生全能性和从体细胞中创造多能细胞的潜力.
主要方法:
- 在小鼠胚芽细胞中对遗传和表观遗传调节者的分析.
- 多能细胞的体外繁殖.
- 在胚胎细胞发育和体细胞分化过程中对表观遗传修饰的研究.
主要成果:
- 确定了控制分化和生殖细胞特异性的关键表观遗传修饰剂.
- 证明胚胎细胞的发育需要体质程序抑制和表观遗传除.
- 展示了多能性基因在生殖细胞全能性再生期间的重新表达.
结论:
- 表观遗传重编程对于生殖细胞发育和全能性至关重要.
- 了解这些机制有助于将体细胞直接重新编程成多能细胞.
相关概念视频
Epigenetic Regulation
Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
Combinatorial Gene Control
Combinatorial gene control is the synergistic action of several transcriptional factors to regulate the expression of a single gene. The absence of one or more of these factors may lead to a significant difference in the level of gene expression or repression.
The expression of more than 30,000 genes is controlled by approximately 2000-3000 transcription factors. This is possible because a single transcription factor can recognize more than one regulatory sequence. The specificity in gene...
The expression of more than 30,000 genes is controlled by approximately 2000-3000 transcription factors. This is possible because a single transcription factor can recognize more than one regulatory sequence. The specificity in gene...
Maintenance of the ES Cell State
The cells of the blastocyst inner cell mass only remain pluripotent for a short time. This state of pluripotency and self-renewal can be maintained in embryonic stem (ES) cell culture by adding specific chemicals or growth factors to ensure the cells can continue dividing and later differentiate into different cell types. In some cases, the cells are grown on a feeder layer of differentiated cells, which provides the growth factors and extracellular matrix components necessary for stem cell...
Somatic to iPS Cell Reprogramming
Reprogramming alters the gene expression in somatic cells, transforming them into induced pluripotent stem (iPS) cells over several generations. Scientists can reprogram cells by introducing genes for four transcription factors—Oct4, Sox2, Klf4, and c-Myc (OSKM) by viral or non-viral methods. These factors are also known as Yamanaka factors after Shinya Yamanaka, who first generated iPS cells using mouse skin cells. Yamanaka was awarded the Nobel Prize in Physiology or Medicine in 2012 for this...
Chromatin Modification in iPS Cells
Chromatin modification alters gene expression; therefore, scientists can add histone-modifying enzymes, histone variants, and chromatin remodeling complexes to somatic cells to aid reprogramming into pluripotent stem (iPS) cells.
Compact chromatin makes reprogramming difficult. Enzymes, such as histone demethylases and acetyltransferases, are often added during reprogramming to loosen the chromatin, making the DNA more accessible to transcription factors. Molecules that inhibit histone...
Compact chromatin makes reprogramming difficult. Enzymes, such as histone demethylases and acetyltransferases, are often added during reprogramming to loosen the chromatin, making the DNA more accessible to transcription factors. Molecules that inhibit histone...
Methods of Nuclear Reprogramming
Nuclear reprogramming is a process of transforming one cell type into an unrelated cell type by epigenetic changes that alter the cell’s original gene expression pattern. Such epigenetic changes force cells to express a different set of genes, which play a significant role in inducing transformation into other cell types. Nuclear reprogramming offers applications in reproductive cloning for livestock propagation and regenerative medicine — developing patient-specific cells for injury repair.


